BrainScope Company, Inc.

Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs

Retrieved on: 
Wednesday, September 1, 2021
Industry, Company, CHEK, Colonoscopy, Clinical research, CRC, Quality of life, Technology, Colon, Cancer, U.S. Securities and Exchange Commission, Medicine, Technion – Israel Institute of Technology, SEC, Polyp, Leadership, Security (finance), Physician, Research, Risk, RF, Syneron Medical, Marketing, Laser, Time, Hebrew University of Jerusalem, Forward-looking statement, Gastrointestinal tract, NASDAQ, Eleazar Sukenik, Patient, Map, BrainScope Company, Inc., Colorectal cancer, FDA, Doctor of Philosophy, Annual report, Medical device, Medical imaging

Dr. Brenner-Lavie will be responsible for leading the Company's overall clinical strategy and implementation as well as driving the Company's clinical direction, including innovation.

Key Points: 
  • Dr. Brenner-Lavie will be responsible for leading the Company's overall clinical strategy and implementation as well as driving the Company's clinical direction, including innovation.
  • Throughout my career, I have focused on the clinical development of user-friendly medical devices that improve a patients' quality of life.
  • Dr. Brenner-Lavie brings more than 15 years of experience in global clinical and regulatory affairs, including experience within the medical devices industry.
  • Dr. Brenner-Lavie will assume all clinical development affairs leadership responsibilities from Dr. Vardit Segal, who served as Vice President of Clinical Affairs of Check-Cap since 2019.

Patterson Companies Fiscal 2022 First-Quarter Conference Call Scheduled for Thursday, September 2, 2021

Retrieved on: 
Friday, August 27, 2021
Medical Devices, Other Health, Health, Veterinary, Dental, Conference, BrainScope Company, Inc., Patterson Companies, Nasdaq, Person, Company, Video game

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2022 first-quarter conference call on Thursday, September 2, 2021 at 7:30 a.m. CT (8:30 a.m.

Key Points: 
  • Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2022 first-quarter conference call on Thursday, September 2, 2021 at 7:30 a.m. CT (8:30 a.m.
  • ET).
  • The companys earnings release will be issued that morning before the market opens.
  • The first-quarter fiscal 2022 earnings conference call replay will be available beginning at 10 a.m. CT (11 a.m.

Global Traumatic Brain Injury Assessment & Management Devices Market Research Report 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 10, 2021
Medical Devices, Health, TBI, Traumatic brain injury, Neurodegeneration, Patient, BrainScope Company, Inc., Brain, Spinal cord, Pressure, Marketing, Head Injuries, US Foods, Device, Athlete, Merck KGaA v. Integra Lifesciences I, Ltd., Injury, Growth, Accident, Intracranial pressure, Revenue, Water management device, Industry, Prevalence, Head injury, Neck, Ageing, CDC, Tissue, Medical device, Health insurance

The "Traumatic Brain Injury Assessment & Management Devices Market Share, Size, Trends, Industry Analysis Report, By Device, By Technique, By End-Use, By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Traumatic Brain Injury Assessment & Management Devices Market Share, Size, Trends, Industry Analysis Report, By Device, By Technique, By End-Use, By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • Furthermore, growing public perception of head injuries, as well as technical advances, have helped the market growth for traumatic brain injury assessment & management devices.
  • Furthermore, industry players are expected to fuel the market growth for traumatic brain injury assessment & management devices during the forecast period by integrating emerging technologies and launching new products.
  • The traumatic brain injury assessment & management devices market report based device, technique, end-use, and region:
    Traumatic Brain Injury Assessment & Management Devices, Devices Outlook (Revenue - USD Billion, 2016 - 2028)

Concussions, Coronavirus, and the Continuum of Care

Retrieved on: 
Thursday, April 16, 2020
Neurotrauma, Medical specialties, Medicine, Articles, Concussion, Telehealth, Traumatic brain injury, Sports injury, Head injury, BrainScope Company, Inc., Concussions in high school sports

With a marked decrease in driving, activities, and organized sports due to government stay-at-home directives, fewer concussions are to be expected.

Key Points: 
  • With a marked decrease in driving, activities, and organized sports due to government stay-at-home directives, fewer concussions are to be expected.
  • Laugel and her team's desire for greater access to care for head injuries led to her launch HeadFirst's telemedicine service.
  • That same care is now available to head trauma patients residing in any setting.
  • A service of urgent care company, Righttime Medical Care, HEADFIRST SPORTS INJURY AND CONCUSSION CARE is a community concussion clinic for the diagnosis, management and treatment of mild Traumatic Brain Injuries (mTBI).

HeadFirst Sports Injury and Concussion Care Opens Its First Head Injury Clinic in St. Mary's County, Maryland

Retrieved on: 
Tuesday, November 26, 2019
Neurotrauma, Health, Medical specialties, Medicine, Psychiatric diagnosis, RTT, Sports injuries, Athletic training, Concussion, Traumatic brain injury, Urgent care center, BrainScope Company, Inc.

HeadFirst Sports Injury and Concussion Care is the premier community concussion clinic for the diagnosis, management, and treatment of mild traumatic brain injuries (TBI).

Key Points: 
  • HeadFirst Sports Injury and Concussion Care is the premier community concussion clinic for the diagnosis, management, and treatment of mild traumatic brain injuries (TBI).
  • The St. Mary's County HeadFirst is the 13th clinic in Maryland, all of which are located within Righttime Care Centers.
  • RIGHTTIME MEDICAL CARE simplifies access to trustworthy medical care for patients of all ages at its 20 urgent care locations in Maryland.
  • A service of Righttime Medical Care, HEADFIRST SPORTS INJURY AND CONCUSSION CARE is a community concussion clinic for the diagnosis, management and treatment of mild Traumatic Brain Injuries (mTBI).

BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics

Retrieved on: 
Thursday, March 28, 2019
Women, Football, Education, University, Technology, Venture capital, Hardware, Health, Clinical trials, Hospitals, Medical devices, Mental health, Professional services, Teens, Defense, Other Defense, Research, Consumer, Sports, Nursing, Science, General Health, MEN, Managed care, Neurotrauma, Medical specialties, Medicine, Psychiatric diagnosis, Health, RTT, Athletic training, Concussion, Intensive care medicine, Traumatic brain injury, BrainScope Company, Inc.

The studies conducted from 2015 through 2019 at 52 clinical sites included nearly 1,700 patients and healthy controls, with over 4,000 evaluations.

Key Points: 
  • The studies conducted from 2015 through 2019 at 52 clinical sites included nearly 1,700 patients and healthy controls, with over 4,000 evaluations.
  • View the full release here: https://www.businesswire.com/news/home/20190328005251/en/
    BrainScope, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment.
  • BrainScope has partnered with the U.S. Department of Defense (DoD) for the development of its mTBI and concussion assessment technology.
  • The clinical study was supported in part by the U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, under Contract No.

Corporate Expansion Leads Righttime Medical Care and HeadFirst Concussion Care to Hire and Promote for Clinical and Operations Roles

Retrieved on: 
Tuesday, February 26, 2019
Medical specialties, Neurotrauma, Health, Psychiatric diagnosis, Athletic training, Concussion, RTT, Urgent care centers, Medicine, Traumatic brain injury, BrainScope Company, Inc., Concussions in high school sports

Dr. Laugel was hired as Medical Director for Righttime's concussion evaluation and treatment program, HeadFirst Sports Injury and Concussion Care.

Key Points: 
  • Dr. Laugel was hired as Medical Director for Righttime's concussion evaluation and treatment program, HeadFirst Sports Injury and Concussion Care.
  • She collaborates with the Righttime Clinical team to focus on quality medical care delivery and serves as a liaison to other community health care partners.
  • RIGHTTIME MEDICAL CAREsimplifies access to trustworthy medical care for patients of all ages at its 18 urgent care locations in Maryland.
  • A service of Righttime Medical Care, HEADFIRST SPORTS INJURY AND CONCUSSION CARE is a community concussion clinic for the diagnosis, management and treatment of mild Traumatic Brain Injuries (mTBI).

BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged Recovery

Retrieved on: 
Tuesday, January 15, 2019
Technology, Venture capital, Hardware, Software, Health, Biotechnology, Other Health, Professional services, Consumer, Family, General Health, Neurotrauma, Traumatology, Medicine, Psychiatric diagnosis, RTT, Health, Athletic training, Concussion, Injuries, Traumatic brain injury, Sports injury, BrainScope Company, Inc.

BrainScope, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that researchers have published preliminary results related to a multi-modal concussion assessment capability for potential severity and likelihood of prolonged recovery from concussions.

Key Points: 
  • BrainScope, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that researchers have published preliminary results related to a multi-modal concussion assessment capability for potential severity and likelihood of prolonged recovery from concussions.
  • Subjects were tested at the time of injury and at multiple time points during recovery.
  • Progressive recovery over time was also demonstrated, especially in the prolonged recovery group.
  • BrainScope noted that while this capability is not currently included in its FDA-cleared product, BrainScope One, the multi-modal biomarker employs BrainScopes technology platform and Intellectual Property portfolio.